VYNE Therapeutics Inc. - VYNE

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$5.339M
QoQ value delta ($000)
+$4.02M (+304.78%)
Implied price effect (QoQ)
+74.27%
Shares
Total shares
9,231,738
QoQ shares delta
+5,257,154 (+132.27%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (VYNE)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q3 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Shay Capital LLC 942 1,624,349 0.1%
Anson Funds Management LP 739 1,274,386 0.07%
Nantahala Capital Management, LLC 580 1,000,000 0.02%
Deeter Investments LLP 580 1,000,000 0.12%
T3 Companies, LLC 548 945,000 0.68%
ACADIAN ASSET MANAGEMENT LLC 370 638,492 0.0%
KVP Capital Advisors, LP 290 500,551 0.28%
VANGUARD GROUP INC 182 314,545 0.0%
Ikarian Capital, LLC 153 264,912 0.01%
ADAR1 Capital Management, LLC 147 253,791 0.01%
GEODE CAPITAL MANAGEMENT, LLC 130 225,152 0.0%
TWO SIGMA INVESTMENTS, LP 127 220,000 0.0%
TWO SIGMA ADVISERS, LP 94 163,100 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 58 100,341 0.0%
Rangeley Capital, LLC 58 100,000 0.05%
BOOTHBAY FUND MANAGEMENT, LLC 47 81,371 0.0%
XTX Topco Ltd 45 79,040 0.0%
JANE STREET GROUP, LLC 41 72,356 0.0%
UBS Group AG 36 62,761 0.0%
GSA CAPITAL PARTNERS LLP 31 53,961 0.0%
STALEY CAPITAL ADVISERS INC 29 51,472 0.0%
BlackRock, Inc. 25 44,405 0.0%
CITADEL ADVISORS LLC 17 30,526 0.0%
Virtu Financial LLC 15 25,327 0.0%
FNY Investment Advisers, LLC 14 25,000 0.0%